
Tharimmune
Biotechnology company developing novel immunotherapies for cancer.
About
Canton Strategic Holdings is the first publicly traded company leveraging Canton Coin and supporting the Canton Network to advance institutional blockchain adoption and the digitization of financial markets. They operate a Super Validator for the Network, ensuring secure transactions, and are focused on the tokenization of real-world assets. The company serves institutional investors and participants in the financial markets.
Listed competitors
Also in this space
Developing novel immunotherapies and diagnostics for cancer.
Shares Immunotherapy, Biotech
A clinical-stage biotechnology company developing novel bispecific and trispecific immunotherapies for the treatment of cancer.
Shares Biotech, MedTech
A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
Shares Immunotherapy, Biotech
Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.
Shares Immunotherapy, Biotech
Developing novel immunotherapies for cancer.
Shares Immunotherapy, Drug Discovery
A global oncology company developing and commercializing innovative cancer treatments.
Shares Biotech, MedTech
Key facts
- Website
- cantonstrategic.com
- Headquarters
- Cambridge, United States
- Founded
- 2017
- Employees
- 13
- Total funding
- $540M
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 3 Nov 2025 | Undisclosed round | $540M |
Tech stack
Detected on cantonstrategic.com, last scanned 22 Oct 2026. Run your own scan
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Tharimmune scores 27. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Tharimmune trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Tharimmune is 81 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Tharimmune raised?
Tharimmune has raised a total of $540M in funding.
How many employees does Tharimmune have?
Tharimmune has approximately 13 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Tharimmune


